Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
Nationally recognized fitness expert Andrea Metcalf of Chicago is showing you how to take it off with her new book, Naked Fitness, A 28 Day Proven Weight Loss Program for a Slimmer, Fitter, Pain-free body, (Vanguard Press) this spring by helping you take the first step: motivation, walking and rewards.
Don’t worry; you won’t have to strip off your clothes…only your fear of looking in the mirror. Metcalf’s plan inspires you to transform body and mind with personalized workouts, meals, beauty consultations, product demonstrations and more. But, if the thought of trying on a bathing suit still isn’t enough motivation to get you off the couch and moving, you’re not alone.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nakedfitness/49063/
Nu Skin’s (NYSE: NUS) revolutionary anti-aging product lineup — ageLOC Transformation daily skin care, including ageLOC Future Serum — is used by more than 50,000 people every day to enjoy a more youthful appearance. The new skin care products were launched in 2010 and are clinically proven to reveal a more youthful appearance in eight key areas beginning after just seven days of use.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nuskin/42697/
On September 15th, Crest and Oral-B announced the kick off of National Gingivitis Awareness Month, with a press conference in Greeley Square Park, Manhattan, featuring “White Collar” star, Tiffani Thiessen. Thiessen is helping Crest and Oral-B to bring attention to the early gum disease, gingivitis, which affects more than fifty percent of American adults¹. Along with the declaration, Crest and Oral-B are helping consumers prevent and reverse gingivitis by introducing a new member to the Crest® Pro-Health® family, Crest® Pro-Health® Clinical Gum Protection. The new, advanced formula of Clinical Gum Protection provides Crest’s highest level of protection against the plaque bacteria that can cause gingivitis and with regular use, is clinically proven to help reverse gingivitis in just four weeks.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/crestprohealth/44592/
In a major advancement for green technology, the TCO Certified eco-label for electronics, together with display industry leader NEC, today announced the NEC MultiSync® EA222WMe computer monitor as the first to receive the TCO Certified Edge award for groundbreaking achievements in environmental design. The award is presented in recognition of NEC’s achievement in eliminating halogens, a proven hazard to human health and the environment.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/tcodevelopment/44213/
